Abeona Therapeutics Inc. ABEO
5.40
(0.03)
(0.55%)
as of 25 Sep
- Market cap
- $303.8M
- P/E
- 0.0×
Follow ABEO
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
4.02 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
P/S ratio |
29.73 | — | 24.06 | 5.09 | 2.48 | 11.93 | — | 113.19 | 855.63 | 192.24 |
P/FCF ratio |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(15.54) | — | (12.80) | (1.61) | (1.11) | (90.36) | — | (20.00) | (141.93) | (50.37) |
P/B ratio |
1.75 | — | 7.97 | 0.84 | 0.79 | 1.42 | — | 2.53 | 4.21 | 1.72 |
Price to Tangible BV |
1.77 | — | 8.80 | 0.89 | 0.82 | 2.12 | — | 5.80 | 5.36 | 2.93 |
EV/Sales |
11.47 | — | 14.52 | (5.07) | (0.60) | 4.42 | — | 86.18 | 695.84 | 118.96 |
EV/EBITDA |
0.00 | — | 0.00 | 0.48 | 0.09 | 0.00 | — | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.41) | — | (1.93) | 0.51 | 0.12 | (1.54) | — | (6.61) | (25.71) | (8.13) |
EV/FCF |
(1.28) | — | (1.92) | 0.53 | 0.12 | (1.48) | — | (5.34) | (24.77) | (7.81) |
Quick Ratio |
6.70 | 6.01 | 4.10 | 6.77 | 3.24 | 2.26 | 3.34 | 4.18 | 24.59 | 8.35 |
Current Ratio |
6.93 | 6.08 | 4.15 | 6.83 | 3.39 | 2.33 | 3.42 | 4.37 | 25.07 | 8.37 |
Net Debt/EBITDA |
2.00 | 1.29 | 1.20 | 0.97 | 0.49 | 1.21 | 1.75 | 1.52 | 5.08 | 3.00 |
Debt/Assets |
9.12% | 17.41% | 0.00% | 11.88% | 11.78% | 2.30% | 3.56% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.13 | 0.43 | 0.00 | 0.29 | 0.22 | 0.03 | 0.04 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.04 | 0.00 | 0.05 | 0.02 | 0.03 | 0.05 | 0.00 | 0.02 | 0.01 | 0.01 |
Operating CF/Net income |
(1.07) | 0.88 | 0.68 | 1.00 | 0.77 | 0.42 | 0.82 | 0.69 | 0.83 | 0.60 |
Capex/Depreciation |
(2.24) | (0.84) | (0.04) | 0.35 | (0.93) | (0.24) | (0.81) | (3.92) | (1.16) | (0.63) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 70.05% | (216.57%) | (260.60%) | (125.79%) | (117.22%) | (59.96%) | (48.82%) | (37.27%) | (20.30%) | (26.22%) | |
| 43.34% | (73.71%) | (84.53%) | (60.47%) | (73.61%) | (44.98%) | (38.35%) | (32.09%) | (18.85%) | (22.89%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (6,756.62%) | (463.12%) | (84.35%) | (74.07%) | (53.78%) | (49.83%) |
Return on Tangible Assets |
38.42% | (71.86%) | (118.19%) | (85.15%) | (163.31%) | (125.53%) | (71.39%) | (72.71%) | (20.03%) | (35.37%) |
Average Days of Receivables |
421.13 | 0.00 | 254.87 | 48.53 | 365.00 | 0.00 | — | 9.86 | 46.66 | 50.91 |
Research and Development Expense of Revenue |
460.69% | 0.00% | 888.31% | 2,048.44% | 1,290.87% | 301.39% | 0.00% | 1,290.79% | 2,029.75% | 1,198.54% |
Selling, General and Administrative Expense of Revenue |
1,117.37% | 0.00% | 542.97% | 1,220.37% | 721.47% | 237.79% | 0.00% | 670.65% | 1,307.41% | 1,494.94% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.22 | 0.31 | 0.43 | 0.20 | 0.37 |
Share Based Compensation of Revenue |
185.21% | 0.00% | 136.23% | 215.77% | 297.20% | 81.87% | 0.00% | 295.73% | 706.81% | 929.25% |
Graham Net Nets |
0.52 | — | 0.06 | 0.70 | 0.57 | 0.34 | — | 0.14 | 0.18 | 0.34 |
Graham Number |
9.41 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Earnings Yield |
24.86% | — | (46.65%) | (213.97%) | (250.00%) | (57.96%) | — | (15.83%) | (3.84%) | (12.80%) |
Free Cash Flow Yield |
(30.21%) | — | (31.41%) | (186.25%) | (208.57%) | (24.99%) | — | (14.25%) | (3.28%) | (7.92%) |
Revenue per Share |
0.11 | 0.00 | 0.16 | 0.18 | 0.76 | 2.70 | 0.00 | 1.58 | 0.50 | 0.65 |
Operating CF per Share |
(1.44) | (1.36) | (1.73) | (5.53) | (16.67) | (9.45) | (31.19) | (20.57) | (13.60) | (9.52) |
Capex per Share |
(0.15) | (0.06) | (0.01) | 0.20 | (1.05) | (0.36) | (3.13) | (4.86) | (0.52) | (0.38) |
Free Cash Flow per Share |
(1.59) | (1.42) | (1.74) | (5.33) | (17.73) | (9.81) | (34.32) | (25.43) | (14.12) | (9.90) |
Cash per Share |
3.61 | 2.39 | 2.46 | 6.68 | 12.93 | 25.64 | 64.17 | 44.69 | 82.71 | 50.57 |
Shareholders Equity per Share |
3.01 | 1.07 | 0.69 | 3.40 | 10.76 | 27.67 | 88.59 | 70.51 | 102.13 | 72.48 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.01 | 1.07 | 0.69 | 3.40 | 10.76 | 27.67 | 88.59 | 70.51 | 102.13 | 72.48 |
Free Cash Flow |
(84.30) | (58.44) | (37.14) | (41.88) | (69.82) | (36.35) | (69.13) | (48.35) | (23.51) | (13.53) |
Working Capital |
175.34 | 84.27 | 42.32 | 45.32 | 39.67 | 55.78 | 93.69 | 68.50 | 134.99 | 61.13 |
Capital Expenditures |
(7.97) | (2.43) | (0.13) | 1.60 | (4.15) | (1.34) | (6.31) | (9.24) | (0.86) | (0.52) |
Net Current Asset Value |
144.55 | 35.95 | 6.56 | 15.65 | 19.07 | 49.10 | 87.44 | 48.50 | 131.92 | 57.46 |
EV/EBIT |
0.00 | — | 0.00 | 0.44 | 0.09 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Capex to Sales |
1.37 | 0.00 | 0.04 | (1.13) | 1.38 | 0.13 | 0.00 | 3.08 | 1.03 | 0.58 |
Net Profit Margin |
1,223.08% | 0.00% | (1,548.23%) | (3,074.82%) | (2,831.20%) | (842.34%) | 0.00% | (1,890.29%) | (3,263.92%) | (2,460.40%) |
Price to Operating Income |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.36 | 0.66 | 0.91 | 0.80 | 0.36 | 0.49 | 0.59 | 0.25 | 0.54 | 1.14 |
Cash ROIC |
(23.27%) | (37.53%) | (60.16%) | (56.66%) | (75.98%) | (23.05%) | (24.07%) | (22.17%) | (7.81%) | (8.16%) |
Accounts Receivable Turnover |
1.39 | 0.00 | 2.66 | 0.89 | 1.95 | 0.00 | — | 31.89 | 7.25 | 7.44 |
Accounts Payable Turnover |
0.27 | 0.00 | 0.87 | 0.15 | 0.99 | 0.00 | 1.76 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
Average Days of Payables |
1,879.56 | 0.00 | 422.54 | 1,468.92 | 353.63 | 0.00 | 158.29 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
1,308.71 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | — |
Average Receivables |
4.18 | 2.05 | 1.32 | 1.59 | 1.54 | — | — | 0.09 | 0.12 | 0.12 |
Average Payables |
5.67 | 2.65 | 1.83 | 3.07 | 4.51 | 4.23 | 4.94 | 4.00 | 2.79 | 2.28 |
Average Assets |
164.25 | 86.47 | 64.11 | 71.90 | 115.39 | 187.29 | 198.89 | 176.58 | 144.91 | 95.56 |
Average Common Equity |
101.62 | 29.43 | 20.79 | 34.56 | 72.46 | 140.49 | 156.24 | 152.07 | 134.60 | 83.41 |
Columns are period end dates